Immunological Responses to Mycobacterial Infections

Mycobacterial pathogens such as Mycobacterium tuberculosis engage a multifaceted host defence that combines innate sensors, cellular effectors and organised structures to contain infection. Alveolar macrophages and dendritic cells serve as first responders, engulfing bacilli and secreting cytokines that recruit monocytes and neutrophils. Activation of the IL-12–IFNγ axis promotes differentiation of CD4+ T helper 1 (Th1) cells, which in turn activate infected macrophages and drive granuloma formation to restrict bacterial growth. CD8+ T cells, natural killer cells and unconventional lymphocytes additionally contribute to cytotoxic clearance and regulation of inflammation. Mycobacteria exploit immune-evasion strategies—such as inhibition of phagosome maturation and modulation of antigen presentation—to persist within host cells, leading to latent infection. A delicate balance between microbial containment and tissue pathology underlies progression to active disease. Understanding this balance has profound implications for vaccine design, diagnostic development and host-directed therapies that aim to restore protective immunity without exacerbating immunopathology.

Research from Nature Portfolio

Recent studies have employed a proteome-wide screening approach to map T cell epitopes recognised during active pulmonary tuberculosis. A comprehensive survey of over twenty thousand mycobacterial peptides identified more than a hundred epitopes eliciting interferon-gamma responses in patients mid-treatment. A subset of antigens derived from cell-wall processes proved highly immunodominant and led to the formulation of a targeted peptide pool capable of distinguishing active cases from latent or uninfected individuals with over 60% sensitivity and 80% specificity across diverse geographies. These findings refine our understanding of stage-specific immunity and offer a versatile tool for diagnostic assays as well as for monitoring vaccine-induced responses.

Immunological Responses to Mycobacterial Infections publication trend

The graph below shows the total number of articles in immunological responses to mycobacterial infections across all publications each year (not limited to Nature Index journals).

Technical terms

Granuloma: A structured aggregate of immune cells, chiefly macrophages and T lymphocytes, formed to contain persistent pathogens.

Epitope: A discrete peptide segment of an antigen recognised by T cell receptors or antibodies.

Proteome-wide screen: Systematic testing of all expressed proteins or peptides from a pathogen to identify immune targets.

Interferon-gamma (IFNγ): A cytokine produced by Th1 cells and natural killer cells that activates macrophages for enhanced microbicidal activity.

Single-cell RNA sequencing (scRNA-seq): A technology that profiles gene expression at the resolution of individual cells.

Bronchoalveolar lavage fluid (BALF): Liquid collected from the lower respiratory tract to analyse resident immune cells and soluble factors.

Th1 cell: A subset of CD4+ T helper cells that produce IFNγ and support cell-mediated immunity against intracellular pathogens.

References

1. Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection. Nature Communications (2024).
2. Single‐Cell Sequencing Reveals Functional Alterations in Tuberculosis. Advanced Science (2024).
3. The interaction of macrophages and CD8 T cells in bronchoalveolar lavage fluid is associated with latent tuberculosis infection. Emerging Microbes & Infections (2023).
4. Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers. JCI Insight (2024).